Cellular Actions of Insulin-Like Growth Factor Binding Proteins
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
The insulin-like growth factors (IGFs), insulin-like growth factor binding proteins (IGFBPs), and the IGFBP proteases are involved in the regulation of somatic growth and cellular proliferation both in vivo and in vitro. IGFs are potent mitogenic agents whose actions are determined by the availability of free IGFs to interact with the IGF receptors. IGFBPs comprise a family of proteins that bind IGFs with high affinity and specificity and thereby regulate IGF-dependent actions. IGFBPs have recently emerged as IGF-independent regulators of cell growth. Various IGFBP association proteins as well as cleavage of IGFBPs by specific proteases modulate levels of free IGFs and IGFBPs. The ubiquity and complexity of the IGF axis promise exciting discoveries and applications for the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865 · cited 1×
“IGFBP-1 is a 25-kDa protein with an RGD sequence in its structure [19,23].”
BackgroundInsulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710 · cited 1×
“Several in vitro studies showed that IGFBP-5 stimulated IGF-l actions when compared to IGF-l alone [53, 72,109,136].”
BackgroundInduction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869 · cited 1×
“necrosis factor-alpha (TNF-α) [55,56], transforming growth factor-beta (TGF- β) [57], retinoic acid [58], PTH [14], osteogenic protein-1 [59], estradiol [60], prostaglandin E2 [61], glucocorticoids [47], and p53 [62].”
Rajah, R., Valentinis, B., & Cohen, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12181 · Cited by 722
Self-citationAn insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.
Elgin, R. G., Busby, W. H., & Clemmons, D. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3254 · Cited by 686
Shimasaki, S., & Ling, N. (1991) · Progress in Growth Factor Research · doi:10.1016/0955-2235(91)90003-m · Cited by 674
Jones, J. I., Gockerman, A., Busby, W. H., Camacho-Hubner, C., & Clemmons, D. R. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.3.679 · Cited by 538 · cited 3×
“Compared to free IGFBP-5, IGFBP-5 bound to the extracellular matrix has lower affinity for IGF-I, but a prolonged half life [53,71].”
BackgroundJones, J. I., Gockerman, A., Busby, W. H., Wright, G., & Clemmons, D. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10553 · Cited by 515 · cited 1×
“However, IGFBP-1 binds specifically to the α5β-integrin receptor and stimulates cell migration of Chinese hamster ovarian cells in a monolayer wounding assay [125].”
BackgroundCohen, P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1046 · Cited by 497
Self-citationDe Mellow, J. S. M., & Baxter, R. C. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80824-6 · Cited by 483
Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
Kelley, K. M., Oh, Y., Gargosky, S. E., Gucev, Z., Matsumoto, T., Hwa, V., Ng, L., Simpson, D. M., & Rosenfeld, R. G. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(96)00005-2 · Cited by 479 · cited 3×
“Unlike other IGFBPs, IGFBP-5 strongly binds to bone cells due to its high affinity for hydroxyapatite [44].”
BackgroundOh, Y., Müller, H. L., Lamson, G., & Rosenfeld, R. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82426-7 · Cited by 472 · cited 13×
“Under strict in vitro conditions, IGFBP-1, -3, and -5 can enhance IGF actions by enhancing IGF-I binding to IGF-IR (Fig.”
BackgroundInfluentialRegulation and Function of Insulin-Like Growth Factor-Binding Protein-1
Lee, P. D. K., Conover, C. A., & Powell, D. R. (1993) · Experimental Biology and Medicine · doi:10.3181/00379727-204-43630 · Cited by 382 · cited 1×
“Glucocorticoids and glucagon stimulate IGFBP-1 production in synergism with low levels of insulin [28–33].”
BackgroundFowlkes, J. L., Enghild, J. J., Suzuki, K., & Nagase, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47310-3 · Cited by 347 · cited 1×
“Categories of IGFBP proteases include kallikreins [81,82], cathepsins [83–86], and matrix metalloproteinases proteases (MMPs) [87–89].”
BackgroundInsulin-Like Growth Factor Binding Proteins in the Human Circulation: A Review
Baxter, R. C. (1994) · Hormone Research · doi:10.1159/000184186 · Cited by 345 · cited 9×
“Hepatic endothelia and Kupffer cells synthesize IGFBP-3, while hepatocytes make IGF-I and ALS [5,6,7].”
BackgroundInfluentialCounts, D. R., Gwirtsman, H., Carlsson, L. M., Lesem, M., & Cutler, G. B. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1381372 · Cited by 344 · cited 1×
“Several studies have shown that insulin inhibits the synthesis of IGFBP-1, resulting in elevated levels during low insulin states such as intrauterine growth retardation, fasting, or poorly controlled Type 1 diabetes mellitus [14,16,26,27,28].”
BackgroundAndress, D. L., & Birnbaum, R. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41695-x · Cited by 343 · cited 5×
“The IGF-enhancing actions of IGFBP-5 are particularly evident in bone cells [72].”
BackgroundInfluentialSmith, W. J. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.2.443 · Cited by 337
Valentinis, B. (1995) · Molecular Endocrinology · doi:10.1210/me.9.3.361 · Cited by 327
Oh, Y., Müller, H. L., Pham, H., & Rosenfeld, R. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74273-2 · Cited by 313
Mohan, S., Nakao, Y., Honda, Y., Landale, E., Leser, U., Dony, C., Lang, K., & Baylink, D. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20424 · Cited by 305 · cited 4×
“In bone, IGFBP-4 is regulated by vitamin D and PTH [67,68].”
BackgroundInfluentialSchedlich, L. J., Young, T. F., Firth, S. M., & Baxter, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18347 · Cited by 272 · cited 1×
“IGFBP-3 and IGFBP-5 have recently been shown to be translocated into the nucleus compatible with having a nuclear localization sequence (NLS) in their mid-region [63,108,137,138].”
BackgroundCohen, P., Peehl, D. M., Graves, H. C. B., & Rosenfeld, R. G. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1420407 · Cited by 268 · cited 2×
“For example, PSAgenerated IGFBP-3 fragments have decreased affinity for IGFs, and prostatic epithelial cells grown in the presence of PSA demonstrate reversal of the inhibitory effects of IGFBP-3 on IGF-stimulated cell growth [93].”
BackgroundSelf-citationLeal, S. M., Liu, Q., Huang, S. S., & Huang, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20572 · Cited by 255
Gucev, Z. S., Oh, Y., Kelley, K. M., & Rosenfeld, R. G. (1996) · PubMed · Cited by 253
Oh, Y., Müller, H. L., Ng, L., & Rosenfeld, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13589 · Cited by 237
Hormonal and Nutritional Regulation of IGF-I and Its Binding Proteins
Underwood, L. E., Thissen, J.-P., Lemozy, S., Ketelslegers, J.-M., & Clemmons, D. R. (1994) · Hormone Research · doi:10.1159/000184187 · Cited by 226 · cited 1×
“IGFBP-3 levels do not change acutely [14], in contrast to IGFBP-1 and -2 levels, which vary throughout the day depending on the metabolic state [13,15].”
BackgroundZapf, J., Hauri, C., Waldvogel, M., Futo, E., Häsler, H., Binz, K., Guler, H. P., Schmid, C., & Froesch, E. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3813 · Cited by 222
Huynh, H., Yang, X., & Pollak, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1016 · Cited by 219 · cited 1×
“necrosis factor-alpha (TNF-α) [55,56], transforming growth factor-beta (TGF- β) [57], retinoic acid [58], PTH [14], osteogenic protein-1 [59], estradiol [60], prostaglandin E2 [61], glucocorticoids [47], and p53 [62].”
Twigg, S. M., & Baxter, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6074 · Cited by 216 · cited 7×
“Hepatic endothelia and Kupffer cells synthesize IGFBP-3, while hepatocytes make IGF-I and ALS [5,6,7].”
BackgroundInfluentialHARDOUIN, S., GOURMELEN, M., NOGUIEZ, P., SEURIN, D., ROGHANI, M., BOUC, Y. L., POVOA, G., MERIMEE, T. J., HOSSENLOPP, P., & BINOUX, M. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-6-1291 · Cited by 188 · cited 1×
“IGFBP-2 gene expression in cultured cells [14,43].”
Blat, C., Villaudy, J., & Binoux, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117229 · Cited by 183
Paolisso, G. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2204 · Cited by 179
Bar, R. S., Boes, M., Clemmons, D. R., Busby, W. H., Sandra, A., Dake, B. L., & Booth, B. A. (1990) · Endocrinology · doi:10.1210/endo-127-1-497 · Cited by 175
Chin, E. (1994) · Endocrinology · doi:10.1210/en.134.6.2498 · Cited by 174
Lalou, C. (1996) · Endocrinology · doi:10.1210/en.137.8.3206 · Cited by 168
Cohen, P. (1993) · Molecular Endocrinology · doi:10.1210/me.7.3.380 · Cited by 165
Self-citationArai, T., Busby, W. H., & Clemmons, D. R. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895319 · Cited by 162
Nuclear Localization of Insulin-Like Growth Factor Binding Protein 3 in a Lung Cancer Cell Line
Jaques, G., Noll, K., Wegmann, B., Witten, S., Kogan, E., Radulescu, R. T., & HAVEMANN, K. (1997) · Endocrinology · doi:10.1210/endo.138.4.5177 · Cited by 153
Firth, S. M., Ganeshprasad, U., & Baxter, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2631 · Cited by 145
Okazaki, R. (1994) · Endocrinology · doi:10.1210/en.134.1.126 · Cited by 143
Phosphorylation of insulin-like growth factor binding proteins
Coverley, J. A., & Baxter, R. C. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04032-x · Cited by 143 · cited 1×
“IGFBP-1 is found in various phosphorylated states that determine its affinity for IGFs [24].”
BackgroundInsulin-like growth factor binding protein (IGFBP) proteases: Functional regulators of cell growth
Rajah, R., Katz, L. E. L., Nunn, S. E., Solberg, P. F. C., Gibson, T. L. B., & Cohen, P. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00012-7 · Cited by 137 · cited 1×
“including prostate cancer and airway smooth muscle hyperplasia of long-standing asthma [89].”
BackgroundSelf-citationBereket, A., Lang, C. H., Blethen, S. L., Fan, J., Frost, R. A., & Wilson, T. A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.8.7543110 · Cited by 137
Price, W. A. (1992) · Endocrinology · doi:10.1210/en.130.3.1424 · Cited by 134
Li, W., Fawcett, J., Widmer, H. R., Fielder, P. J., Rabkin, R., & Keller, G.-A. (1997) · Endocrinology · doi:10.1210/endo.138.4.5176 · Cited by 128
Vaccarello, M. A., Diamond, F., Guevara‐Aguirre, J., Rosenbloom, A. L., Fielder, P. J., Gargosky, S. E., Cohen, P., Wilson, K. F., & Rosenfeld, R. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.1.7686916 · Cited by 127
Self-citationRusso, V. C., Bach, L. A., Fosang, A., Baker, N. L., & Werther, G. A. (1997) · Endocrinology · doi:10.1210/endo.138.11.5472 · Cited by 127
IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.
Booth, B. A., Boes, M. K., Dl, A., Dake, B. L., Kiefer, M. C., Maack, C. A., Rj, L., Bar, K., Ee, C., & Weiler, J. M. (1995) · PubMed · Cited by 126
Unterman, T. G., OEHLER, D. T., Murphy, L. J., & Lacson, R. (1991) · Endocrinology · doi:10.1210/endo-128-6-2693 · Cited by 123 · cited 1×
“Several studies have shown that insulin inhibits the synthesis of IGFBP-1, resulting in elevated levels during low insulin states such as intrauterine growth retardation, fasting, or poorly controlled Type 1 diabetes mellitus [14,16,26,27,28].”
BackgroundConover, C. A., & León, D. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37248-4 · Cited by 123
Nickerson, T., Pollak, M., & Huynh, H. T. (1998) · Endocrinology · doi:10.1210/endo.139.2.5912 · Cited by 122 · cited 1×
“In a different model, rat ventral prostate following castration rapidly increased gene expression of IGFBP-2 through -5 in association with apoptosis [65].”
BackgroundFowlkes, J. L., Suzuki, K., Nagase, H., & Thrailkill, K. M. (1994) · Endocrinology · doi:10.1210/endo.135.6.7527335 · Cited by 120
Clemmons, D. R., Cascieri, M. A., Camacho‐Hübner, C., McCusker, R. H., & BAYNE, M. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38332-2 · Cited by 118
Leukotriene D4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis
Cohen, P., Noveral, J. P., Bhala, A., Nunn, S. E., Herrick, D. J., & Grunstein, M. M. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.269.2.l151 · Cited by 108 · cited 1×
“Concentrations of IGFBP-2 are age-dependent with high levels seen in infancy and older age and low levels in young adults [39].”
BackgroundSelf-citationClinical aspects of insulin-like growth factor binding proteins.
Cohen, P., Fielder, P. J., Hasegawa, Y., Frisch, H., Giudice, L. C., & Rosenfeld, R. G. (1991) · PubMed · Cited by 105
Self-citationOlney, R. C. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.1096 · Cited by 103
Mohan, S., Libanati, C. R., Dony, C., Lang, K., Srinivasan, N., & Baylink, D. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7545694 · Cited by 102
Conover, C. A., Perry, J. E., & Tindall, D. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7533776 · Cited by 102
Mohan, S., Farley, J. R., & Baylink, D. J. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00027-5 · Cited by 101 · cited 1×
“Levels in older women are approximately 30% of teenagers [17,18].”
BackgroundArany, E. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1871 · Cited by 100
Proteolysis of Insulin-Like Growth Factors (IGF) and IGF Binding Proteins by Cathepsin D
Claussen, M., Kübler, B., Wendland, M., Neifer, K., Schmidt, B., Zapf, J., & Braulke, T. (1997) · Endocrinology · doi:10.1210/endo.138.9.5418 · Cited by 98
Duan, C., Hawes, S. B., Prevette, T., & Clemmons, D. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4280 · Cited by 98 · cited 2×
“IGFBP-6 is an O-glycosylated protein [76] with a predicted molecular weight of 34 kDa [4].”
BackgroundFunctional Role of Insulin-Like Growth Factor Binding Proteins
Ranke, M. B., & Elmlinger, M. W. (2009) · Hormone Research · doi:10.1159/000191304 · Cited by 93 · cited 1×
“IGFBP-1, -2, and possibly -4 can also transport IGFs between the intra- and extravascular space [110].”
BackgroundTsuboi, R., Shi, C.-M., Sato, C., Cox, G. N., & Ogawa, H. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12612755 · Cited by 91 · cited 1×
“IGFBP-1 has also been shown to stimulate wound healing in diabetic rabbits [127].”
BackgroundKhosravi, M. J., Diamandi, A., Mistry, J., Krishna, R., & Khare, A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4415 · Cited by 91
Han, G.-R., Dohi, D. F., Lee, H.-Y., Rajah, R., Walsh, G. L., Hong, W. K., Cohen, P., & Kurie, J. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13711 · Cited by 91
Self-citationMuller, H. L., Oh, Y., Lehrnbecher, T., Blum, W. F., & Rosenfeld, R. G. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.7519190 · Cited by 89
Fowlkes, J. L. (1997) · Endocrinology · doi:10.1210/en.138.6.2280 · Cited by 88
IL-6 Stimulation of Insulin-like Growth Factor Binding Protein (IGFBP)-1 Production
Samstein, B., Hoimes, M. L., Fan, J., Frost, R. A., Gelato, M. C., & Lang, C. H. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1705 · Cited by 84
Human insulin-like growth factor binding protein-6 is O-glycosylated
Bach, L. A., THOTAKURA, N. R., & Rechler, M. M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80807-1 · Cited by 84
Villafuerte, B. C., Koop, B. L., Pao, C.-I., Gu, L., Birdsong, G. G., & Phillips, L. S. (1994) · Endocrinology · doi:10.1210/en.134.5.2044 · Cited by 83
Olney, R. C., Wilson, D. M., Mohtai, M., Fielder, P. J., & Smith, R. L. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1460279 · Cited by 81
Galiano, R. D., Zhao, L. L., Clemmons, D. R., Roth, S. I., Lin, X.-M., & Mustoe, T. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119064 · Cited by 81
Strasser-Vogel, B., Blum, W. F., Past, R., Kessler, U., Hoeflich, A., Meiler, B., & Kiess, W. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7536202 · Cited by 80 · cited 2×
“Several studies have shown that insulin inhibits the synthesis of IGFBP-1, resulting in elevated levels during low insulin states such as intrauterine growth retardation, fasting, or poorly controlled Type 1 diabetes mellitus [14,16,26,27,28].”
BackgroundConover, C. A., Bale, L. K., Clarkson, J. T., & Törring, O. (1993) · Endocrinology · doi:10.1210/endo.132.6.7684979 · Cited by 80
Jyung, R. W., Mustoe, J. A., Busby, W. H., & Clemmons, D. R. (1994) · PubMed · Cited by 79
Baxter, R. C., & Saunders, H. (1992) · Journal of Endocrinology · doi:10.1677/joe.0.1340133 · Cited by 76 · cited 4×
“In osteoblastic cells, the addition of excessive concentration of IGFBP-6 inhibited IGF-II-stimulated DNA and glycogen synthesis, but had minimal effects on inhibiting IGF-I actions [16].”
BackgroundInfluentialMohseni-Zadeh, S., & Binoux, M. (1997) · Endocrinology · doi:10.1210/endo.138.12.5714 · Cited by 74
Conover, C. A., Lee, P., Riggs, B. L., & Powell, D. R. (1996) · Endocrinology · doi:10.1210/endo.137.8.8754754 · Cited by 72
Gutiérrez‐Ospina, G., Calikoglu, A. S., Ye, P., & D’Ercole, A. J. (1996) · Endocrinology · doi:10.1210/endo.137.12.8940375 · Cited by 65 · cited 1×
“Another transgenic mouse which had equally high levels of serum IGFBP-1 did not confirm the growth retardation observed in Murphy's model [36].”
BackgroundRegulation of Myeloid Growth and Differentiation by the Insulin-Like Growth Factor I Receptor
Li, Y. M., Schacher, D. H., Liu, Q., Arkins, S., Rebeiz, N., McCusker, R. H., Dantzer, R., & Kelley, K. W. (1997) · Endocrinology · doi:10.1210/endo.138.1.4847 · Cited by 63
Karas, M., Danilenko, M., Fishman, D., LeRoith, D., Levy, J., & Sharoni, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16514 · Cited by 63
Besset, V., Magueresse‐Battistoni, B. L., Collette, J., & Benahmed, M. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536626 · Cited by 63
Conover, C. A., Clarkson, J. T., & Bale, L. K. (1995) · Endocrinology · doi:10.1210/endo.136.4.7534698 · Cited by 61
Katz, L. E. L., Satin-Smith, M. S., Collett‐Solberg, P. F., THORNTON, P. S., Baker, L., Stanley, C. A., & Cohen, P. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70153-7 · Cited by 60 · cited 2×
“In children with ketotic hypoglycemia who underwent diagnostic fasting studies, their IGFBP-1 levels were as high as 700 ng/dL at times of hypoglycemia (serum glucose < 60 mg/dL) [25].”
BackgroundSelf-citationInsulin‐like growth factor binding proteins and their regulation
Rosenfeld, R. G., Pham, H. M., Cohen, P., Fielder, P. J., Gargosky, S. E., Muller, H. L., Nonoshita, L., & Oh, Y. (1994) · Acta Paediatrica · doi:10.1111/j.1651-2227.1994.tb13315.x · Cited by 60 · cited 3×
“In a large population of GH receptor-deficient patients from Ecuador, however, administration of IGF-I stimulated growth but did not change IGFBP-3 levels by radioimmunoassay (RIA) [8,49].”
BackgroundSelf-citationKanety, H., Karasik, A., Klinger, B., Silbergeld, A., & Laron, Z. (1993) · Acta Endocrinologica · doi:10.1530/acta.0.1280144 · Cited by 59
Murphy, L. J., Rajkumar, K., & Molnár, P. J. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00026-7 · Cited by 55 · cited 2×
“Moreover, compared to wild-type mice, certain transgenic mice which overproduce IGFBP-1 have significantly lower birthweights, poorer post-natal weight gain, and disproportionately smaller brains [35].”
BackgroundCANALIS, E. M., & Gabbitas, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10771 · Cited by 55 · cited 2×
“In the same cell system, treatment with IGF-I and retinoic acid caused the opposite effect, increasing levels of IGFBP-5 mRNA [73,74].”
BackgroundHashimoto, R., Ono, M., Fujiwara, H., Higashihashi, N., Yoshida, M., Enjoh, T., & Sakano, K.-I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27936 · Cited by 52
Clinical Significance of Insulin-Like Growth Factor Binding Proteins (IGFBPs)
Katz, L. E. L., Rosenfeld, R. G., & Cohen, S. P. (1995) · The Endocrinologist · doi:10.1097/00019616-199501000-00006 · Cited by 50 · cited 12×
“necrosis factor-alpha (TNF-α) [55,56], transforming growth factor-beta (TGF- β) [57], retinoic acid [58], PTH [14], osteogenic protein-1 [59], estradiol [60], prostaglandin E2 [61], glucocorticoids [47], and p53 [62].”
BackgroundInfluentialSelf-citationLEMMEY, A. B., Glassford, J., Flick-Smith, H. C., Holly, J. M. P., & Pell, J. M. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1540319 · Cited by 49 · cited 1×
“In support of the third mechanism, some in vitro studies have shown that: (a) GH can induce IGFBP-3 message expression in many tissues (rat liver, skin, and muscle); and (b) IGF-I can induce an increase in serum IGFBP-3 concentration in the absence of an increase in hepatic IGFBP-3 mRNA levels and despite a paucity of…”
Regulation of the insulin-like growth factor system by acute acidosis
Bereket, A., Wilson, T. A., Kolasa, A. J., Fan, J., & Lang, C. H. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641171 · Cited by 43
The RIA for IGFBP-2 in man--a meagre catch?
Schwander, J., & Jl, M. (1993) · PubMed · Cited by 40
Claussen, M., Bürgisser, D., Schuller, A. G., Matzner, U., & Braulke, T. (1995) · Molecular Endocrinology · doi:10.1210/me.9.7.902 · Cited by 39
Kanzaki, S., Baxter, R. C., Knutsen, R., Baylink, D. J., & Mohan, S. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100605 · Cited by 38 · cited 1×
“Stimulation of bone cells with growth hormone (but not IGF-I) caused an increase in IGFBP-3 expression [54].”
BackgroundMatsui, T., Hirai, M., Hirano, M., & Kurosawa, Y. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81620-f · Cited by 38
Effects of renal failure on the growth hormone–insulin-like growth factor axis
Powell, D. R. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70003-9 · Cited by 37 · cited 1×
“Studies in vivo have also suggested that IGFBPs inhibit growth by reducing the free IGF level [105,106].”
BackgroundLevitt Katz, L. E., Satin-Smith, M. S., Collett-Solberg, P., Baker, L., Stanley, C. A., & Cohen, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5347 · Cited by 36 · cited 1×
“Glucocorticoids and glucagon stimulate IGFBP-1 production in synergism with low levels of insulin [28–33].”
BackgroundSelf-citationTHE ROLE OF IGFBP-3 IN THE REGULATION OF IGFBP-4 PROTEOLYSIS
Donnelly, M., & Holly, J. M. P. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.149r001 · Cited by 36 · cited 1×
“Similar findings have been demonstrated in dermal fibroblasts [98].”
ResultProperties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3).
Sommer, A., Spratt, S. K., Tatsuno, G. P., Tressel, T. J., Lee, R., & Maack, C. A. (1993) · PubMed · Cited by 35
Reeve, J. G., Guadaño, A., Xiong, J., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.135 · Cited by 30 · cited 2×
“Simian virus 40-transformed fibroblasts have dramatically lower IGFBP-5 expression compared to their normal counterparts [144,145].”
BackgroundMethodNunn, S. E., Peehl, D. M., & Cohen, P. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199705)171:2<196::aid-jcp10>3.0.co;2-c · Cited by 29 · cited 1×
“Categories of IGFBP proteases include kallikreins [81,82], cathepsins [83–86], and matrix metalloproteinases proteases (MMPs) [87–89].”
BackgroundSelf-citationStructure and function of the HOX A1 human homeobox gene cDNA
Hong, Y. S., Kim, S. Y., Bhattacharya, A., Pratt, D. R., Hong, W. K., & Tainsky, M. A. (1995) · Gene · doi:10.1016/0378-1119(95)92712-g · Cited by 28
Protein phosphatase 2A in stretch‐induced endothelial cell proliferation
Murata, K., Mills, I., & Sumpio, B. E. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19961201)63:3<320::aid-jcb7>3.0.co;2-z · Cited by 15 · cited 1×
“necrosis factor-alpha (TNF-α) [55,56], transforming growth factor-beta (TGF- β) [57], retinoic acid [58], PTH [14], osteogenic protein-1 [59], estradiol [60], prostaglandin E2 [61], glucocorticoids [47], and p53 [62].”
Cited by
Circulating Insulin-Like Growth Factor I Mediates Effects of Exercise on the Brain
Carro, E., Nuñez, A., Busiguina, S., & Torres-Aleman, I. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02926.2000 · Cited by 762
“The CSF contains IGFs and IGF-binding proteins (IGFBPs) (Ferry et al., 1999).”
BackgroundRole of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
Grimberg, A., & Cohen, P. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<1::aid-jcp1>3.0.co;2-j · Cited by 506
Self-citationThe Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
Moschos, S. J., & Mantzoros, C. S. (2002) · Oncology · doi:10.1159/000066230 · Cited by 371
Metadata
- Authors
- Ferry, R., Katz, L., Grimberg, A., Cohen, P., & Weinzimer, S.
- Venue
- Hormone and Metabolic Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 1999-01
- Volume
- 31
- Issue
- 02/03
- Pages
- 192-202
- ISSN
- 0018-5043 (ISSN-L)
- 1439-4286
- OpenAlex
- W1966051337
- Cited by
- 166
- References
- 106
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.